Table 2. Details of Extracellular vesicle isolation and characterization techniques for their diagnostic role.
| Study Name | Sample | Source of EVs |
EV isolation technique | EV characterisation techniques used |
EV concentration | EV size (mean, in nanometers) |
Markers for EV validation |
|---|---|---|---|---|---|---|---|
| Ferrant J et al.1 | SS and healthy controls | Plasma | Size-exclusion chromatography | NTA, flow cytometry | 5×1010 (approx from graph) | 110−150 | NA |
| Aqrawi et al.2 | SS and healthy controls | Tears and saliva | Size-exclusion chromatography | NTA, flow cytometry | Tears SS 1.09×109 ± 1.06×108 Control, 1.54×109 ± 3.08×108 Saliva SS 5.46×1010 ± 1.43×1010Controls 2.41×109 ± 3.98×109 |
Tears SS 171 ± 6.9Control, 163 ± 9.6Saliva SS 189 ± 4.1Controls 189 ± 4.4 |
CD9 |
| Aqrawi et al.3 | SS, non-SS and healthy controls | Tears and saliva | Size-exclusion chromatography | NTA, immunoaffinity capture, flow cytometry | Tears (SS, 5.0×108, Non-SS, 1.2×109Controls, 7.1×108) Saliva (SS, 1.9×1010± 0.7×109, Non-SS, 1.0×1010± 1.6×109 Controls, 7.9×109± 1.6×109 | Tears (SS, 255 ± 40,Non-SS, 204 ± 8Controls, 215 ± 9) Saliva (SS, 233 ± 17,Non-SS, 231 ± 13Controls, 264 ± 6 | CD9, CD−44 |
| Kakan SS et al.4 | NOD mice model | Plasma | Differential ultracentrifugation for discovery experiments and with SEC | RNA isolation, TEM, Western blotting, NTA | N/A | Median 136 nm (male NOD serum with UC), 131 nm (BALB/c mouse serum with UC).SEC-median diameter of 122 nm in both strains. | TSG101 |
| Li F et al.5 | SS and non-SS | MSGs and plasma | Total Exosome Isolation Kit (Invitrogen) | Not done | NA | NA | NA |
| Yamashiro K et al.6 |
SS and healthy controls | Mouth rinse | Ultracentrifugation | NTA, western blot | NA | 145 | CD9, CD63 |
| Cross T et al.8 | SS and healthy controls | Saliva | Size-exclusion chromatography and modified Qiagen exoRNeasy EV isolation | NTA, TEM, Immunoaffinity capture and Western blot | 2.0 x109 particles/mL | 154 | CD9, CD63, Hsp70 |
| Pucker et al.9 | DED and non-DED | Tears | Polyethylene glycol (PEG) 8000 |
TEM, ELISA | 550,000 in DED 600,000 in non DED | NA | CD63 |
| Cross T et al.10 | DED | Tears | Modified Qiagen exoRNeasy column approach | NTA, TEM, Flow cytometry, western blot | ~108 particles/mL | 100−350 | Tetraspanin CD9 (flow cytometry), CD9, CD−63, Hsp70 |
SS − Sjögren’s Syndrome, DED − Dry Eye Disease, NTA − Nanoparticle Tracking Analysis, NOD − Non-Obese Diabetic, TEM − Transmission Electron Microscopy, SEC − Size Exclusion Chromatography, UC - Ultracentrifugation, MSG − Minor Salivary Gland